Literature DB >> 2199594

Transport and functions of carnitine in muscles.

N Siliprandi1, F Di Lisa, R Menabó, M Ciman, L Sartorelli.   

Abstract

The transport, function and metabolism of carnitine are discussed with regard to their importance in clinical chemistry. In humans carnitine is synthesized from protein-derived trimethyllysine in liver, brain and kidney. Muscles take up carnitine from the blood in an exchange-diffusion process with endogenous deoxycarnitine, the immediate precursor of carnitine. Besides catalysing the transport of long-chain acyl groups in mitochondria, carnitine is necessary for the export of intramitochondrially produced short-chain acyl residues and for the trapping and the elimination of unphysiological compounds (benzoic, pivalic, valproic acids etc.). The detection and quantitation in urine of these physiological and unphysiological carnitine esters is necessary for the diagnosis of carnitine deficiencies. The carnitine esters may be eliminated in the urine and/or distributed in tissues, where some of them (acetyl-, propionyl- and isovaleryl-carnitine) may be utilized for specific purposes. The most important carnitine-dependent metabolic disorders are listed according to their causes.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2199594

Source DB:  PubMed          Journal:  J Clin Chem Clin Biochem        ISSN: 0340-076X


  4 in total

1.  Activation of the Ca2+ release channel of skeletal muscle sarcoplasmic reticulum by palmitoyl carnitine.

Authors:  R el-Hayek; C Valdivia; H H Valdivia; K Hogan; R Coronado
Journal:  Biophys J       Date:  1993-08       Impact factor: 4.033

2.  Role of carnitine in cancer chemotherapy-induced multiple organ toxicity.

Authors:  Mohamed M Sayed-Ahmed
Journal:  Saudi Pharm J       Date:  2010-08-05       Impact factor: 4.330

3.  L-carnitine: a partner between immune response and lipid metabolism ?

Authors:  G Famularo; S Tzantzoglou; G Santini; V Trinchieri; S Moretti; A Koverech; C De Simone
Journal:  Mediators Inflamm       Date:  1993       Impact factor: 4.711

4.  Carnitine insufficiency is associated with fatigue during lenvatinib treatment in patients with hepatocellular carcinoma.

Authors:  Hironao Okubo; Hitoshi Ando; Kei Ishizuka; Ryuta Kitagawa; Shoki Okubo; Hiroaki Saito; Shigehiro Kokubu; Akihisa Miyazaki; Kenichi Ikejima; Shuichiro Shiina; Akihito Nagahara
Journal:  PLoS One       Date:  2020-03-03       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.